Trial of new cancer antibody approved.
Israel’s cCAM has received US FDA approval to commence trials of its CM-24 monoclonal antibody (mAb) for the treatment of various types of cancers. CM-24 targets CEACAM1, a novel immune checkpoint protein expressed on a variety of cancer cells.
Israel & USA team up to fight cancer.
Israeli biotech Compugen has enlisted John Hopkins University to help assess Compugen’s cancer immunotherapy candidates. These new treatments aim to counter the ability of tumors to highjack “immune checkpoints”, thereby blocking the immune system’s ability to destroy the tumor.
Effective for detecting lingering cancer cells.
New York City’s NYU Langone Medical Center has praised MarginProbe from Israel’s Dune Medical, used by surgeons to identify and help them remove cancer cells on the margins of removed tumors. MarginProbe avoids the need for follow-up surgery.
90% response to cancer vaccine.
Julian Levy, CFO of Israel’s Vaxil Biotherapeutics speaks to NoCamels about Vaxil’s cancer vaccine, ImMucin, that boosts the immune system and prevents cancer returning. ImMucin triggers a response in about 90 percent of all types of cancer.
US approve 360-degree colonoscope.
Israel’s GI View has just received US FDA approval for its Aer-O-Scope colonoscope, for advanced detection of polyps that frequently develop into colon cancer. GI View is expected to start selling the product in the U.S. in early 2016.
Spine surgery system wins two awards.
Israel’s NLT-Spine has won a 2014 Spine Technology Award from US Magazine Orthopedics This Week, for its ARC Pedicle Screw System. The company also was included (for the second year running) in the list of Red Herring Global 100 winners.
Med school at 16.
If Israelis are exceptional people, then Maya Fishman is amazing. Only 16-years old, she has already started med school at the Hebrew University in Jerusalem. She is on course to become the youngest doctor in the history of the State of Israel.
What lurks in your lungs?
Professor Elizabeth Fireman of Tel Aviv’s Sourasky Medical Center has developed a highly accurate bio-monitoring technique to detect dangerous particles inhaled by firefighters, factory workers, dental technicians and kids with asthma.